Comis Rl

2.6k total citations
11 papers, 337 citations indexed

About

Comis Rl is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Comis Rl has authored 11 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Comis Rl's work include Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Comis Rl is often cited by papers focused on Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Comis Rl collaborates with scholars based in United States. Comis Rl's co-authors include Anthony J. Scalzo, M Pfeffer, Robert Gilbert, Baker Lh, P J O'Dwyer, Kennedy Bj, T C Hamilton, Deborah Kilpatrick, J. Matthew Brennan and Dan Anbar and has published in prestigious journals such as European Journal of Cancer and PubMed.

In The Last Decade

Comis Rl

11 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Comis Rl United States	6	190	151	60	57	39	11	337
G Mathé France	9	170 0.9×	120 0.8×	58 1.0×	37 0.6×	33 0.8×	48	386
Deborah S. White United States	10	198 1.0×	150 1.0×	58 1.0×	29 0.5×	39 1.0×	13	511
Jane C. Wright United States	14	215 1.1×	144 1.0×	93 1.6×	24 0.4×	41 1.1×	42	490
J. Schüller Austria	11	251 1.3×	58 0.4×	69 1.1×	22 0.4×	61 1.6×	30	351
Brian M.J. Cantwell United Kingdom	12	236 1.2×	126 0.8×	83 1.4×	46 0.8×	16 0.4×	21	369
Henry J. Durivage United States	12	226 1.2×	218 1.4×	68 1.1×	28 0.5×	39 1.0×	21	458
JN Ingle United States	11	270 1.4×	62 0.4×	47 0.8×	29 0.5×	27 0.7×	27	413
Schutt Aj United States	11	227 1.2×	92 0.6×	74 1.2×	135 2.4×	105 2.7×	33	422
F Turpin France	10	247 1.3×	85 0.6×	68 1.1×	18 0.3×	17 0.4×	35	410
DavidS. Alberts United States	9	167 0.9×	135 0.9×	71 1.2×	18 0.3×	123 3.2×	9	455

Countries citing papers authored by Comis Rl

Since Specialization

Citations

This map shows the geographic impact of Comis Rl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Comis Rl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Comis Rl more than expected).

Fields of papers citing papers by Comis Rl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Comis Rl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Comis Rl. The network helps show where Comis Rl may publish in the future.

Co-authorship network of co-authors of Comis Rl

This figure shows the co-authorship network connecting the top 25 collaborators of Comis Rl. A scholar is included among the top collaborators of Comis Rl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Comis Rl. Comis Rl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Rl, Comis, et al.. (1998). Small-cell lung cancer: a perspective on the past and a preview of the future.. PubMed. 12(1 Suppl 2). 44–50. 21 indexed citations

2.

Hamilton, T C, et al.. (1993). Phase I trial of buthionine sulfoximine (BSO) in combination with melphalan. European Journal of Cancer. 29. S119–S119. 1 indexed citations

3.

O'Dwyer, P J & Comis Rl. (1989). Schedule as a determinant of cytotoxic drug activity.. PubMed. 1(2). 174–8. 4 indexed citations

4.

Rl, Comis. (1986). Oral etoposide in small-cell lung cancer.. PubMed. 13(3 Suppl 3). 75–8. 4 indexed citations

5.

Pfeffer, M, et al.. (1985). Bioavailability and pharmacokinetics of etoposide (VP-16).. PubMed. 12(1 Suppl 1). 48–51. 78 indexed citations

6.

Rl, Comis, et al.. (1983). Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).. PubMed. 67(1). 95–6. 2 indexed citations

7.

Rl, Comis, et al.. (1982). Small cell anaplastic carcinoma of the lung. The Cancer and Leukemia Group B Experience.. PubMed. 69(1). 79–82. 6 indexed citations

8.

Rl, Comis, et al.. (1981). Phase I trial of chlorozotocin: attempted amelioration of myelotoxicity by glucose administration.. PubMed. 65(7-8). 647–50. 3 indexed citations

9.

Lh, Baker, et al.. (1979). American experience with carminomycin.. PubMed. 63(5). 899–902. 10 indexed citations

10.

Rl, Comis, et al.. (1979). Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.. PubMed. 39(12). 5076–80. 79 indexed citations

11.

Rl, Comis. (1976). DTIC (NSC-45388) in malignant melanoma: a perspective.. PubMed. 60(2). 165–76. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact